Last reviewed · How we verify
NCT04994418
The Impact of Sodium and Fructose on Blood Pressure and Inflammation
NA trial testing Recommended sodium and low fructose diet in Blood Pressure in 91 participants. Completed in 15 April 2024.
15 April 2024
Quick facts
| Lead sponsor | University of Delaware |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 91 |
| Start date | 1 April 2021 |
| Primary completion | 15 April 2024 |
| Estimated completion | 15 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Recommended sodium and low fructose diet
- High sodium and low fructose diet
- High sodium and high fructose diet
Conditions studied
- Blood Pressure — all drugs for Blood Pressure →
- Inflammation — all drugs for Inflammation →
Sponsor
University of Delaware
Who can join
Adults 18 to 45, any sex, with Blood Pressure or Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to determine the impact of dietary sodium and fructose on blood pressure and inflammation in young healthy adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The impact of dietary sodium and fructose on renal sodium handling and blood pressure in healthy adults.
McMillan RK, Stock JM, Romberger NT, Wenner MM, et al · · 2025 · cited 3× · PMID 40129273 · DOI 10.14814/phy2.70284
Verify or expand the search:
- PubMed search for NCT04994418
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Pressure
Currently open trials in the same condition.
- NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
- NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
- NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
- NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
- NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting
Other University of Delaware trials
Trials by the same sponsor.
- NCT07420218 — Menopausal Hormones and Sympathetic Activation · Phase 4 · not yet recruiting
- NCT07536217 — Developmental Pilot of Support Groups for Caregivers of Children With DLD · NA · enrolling by invitation
- NCT07054840 — Pain and Split-belt Motor Learning in Older Adults · NA · recruiting
- NCT06916260 — Light Therapy Intervention in Individuals With Parkinson's Disease · NA · recruiting
- NCT07071077 — Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04994418 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Delaware
- Last refreshed: 6 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04994418.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing